Pioneer Green Farms, Inc. (PGFF) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
1301 10TH STREET PALMETTO, FL 34221 |
| State of Incorp. | FL |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2833 - Medicinal Chemicals and Botanical Products (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 6/30/2024 MRQ | 12/31/2023 | 12/31/2022 | |||
|---|---|---|---|---|---|
| ASSETS | |||||
| Current Assets | |||||
| Cash, cash equivalents, and short-term investments | 1 | 12 | |||
| Cash and cash equivalents | 1 | 12 | |||
| Inventory, net of allowances, customer advances and progress billings | 15 | 21 | |||
| Inventory | 15 | 21 | |||
| Other current assets | 5 | ||||
| Other undisclosed current assets | 5 | ||||
| Total current assets: | 26 | 32 | |||
| Noncurrent Assets | |||||
| Operating lease, right-of-use asset | 186 | 190 | |||
| Property, plant and equipment | 381 | 390 | |||
| Total noncurrent assets: | 567 | 580 | |||
| TOTAL ASSETS: | 593 | 613 | |||
| LIABILITIES AND EQUITY | |||||
| Liabilities | |||||
| Current Liabilities | |||||
| Debt | 311 | 288 | |||
| Other liabilities | 600 | ||||
| Due to related parties | ✕ | ✕ | 321 | ||
| Other undisclosed current liabilities | 85 | 124 | |||
| Total current liabilities: | 996 | 733 | |||
| Noncurrent Liabilities | |||||
| Liabilities, other than long-term debt | 209 | 210 | |||
| Operating lease, liability | 209 | 210 | |||
| Total noncurrent liabilities: | 209 | 210 | |||
| Total liabilities: | 1,205 | 943 | |||
| Equity | |||||
| Equity, attributable to parent | (612) | (331) | |||
| Common stock | 0 | 0 | |||
| Common stock, value, subscriptions | 109 | 44 | |||
| Additional paid in capital | 902 | 846 | |||
| Accumulated deficit | (1,623) | (1,220) | |||
| Total equity: | (612) | (331) | |||
| TOTAL LIABILITIES AND EQUITY: | 593 | 613 | |||
Income Statement (P&L) ($ in thousands)
| 6/30/2024 TTM | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|
| Revenues | 9 | |||
| Cost of revenue | (5) | |||
| Gross profit: | 4 | |||
| Operating expenses | (395) | (500) | ||
| Operating loss: | (391) | (500) | ||
| Nonoperating income (expense) (Other Nonoperating Income (Expense)) | 0 | (15) | ||
| Interest and debt expense | (13) | (110) | ||
| Loss from continuing operations before equity method investments, income taxes: | (403) | (624) | ||
| Other undisclosed loss from continuing operations before income taxes | ||||
| Net loss available to common stockholders, diluted: | (403) | (624) | ||
Comprehensive Income ($ in thousands)
| 6/30/2024 TTM | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|
| Net loss: | (403) | (624) | ||
| Comprehensive loss, net of tax, attributable to parent: | (403) | (624) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.